Focal T2 and FLAIR hyperintensities within the infarcted area: A suitable marker for patient selection for treatment?
Julia MeisterernstPascal P Klinger-GratzLars LeidoltMatthias F LangGerhard SchrothPasquale MordasiniMirjam R HeldnerMarie-Luise MonoRebekka KurmannMonika BuehlmannUrs FischerMarcel ArnoldJan GrallaHeinrich P MattleMarwan El-KoussySimon JungPublished in: PloS one (2017)
Our results question the assumption that T2 or FLAIR hyperintensities within the ischemic lesion should be used to exclude patients from reperfusion therapy, especially not from endovascular treatment.
Keyphrases
- endovascular treatment
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- cerebral ischemia
- prognostic factors
- acute myocardial infarction
- peritoneal dialysis
- heart failure
- oxidative stress
- ischemia reperfusion injury
- coronary artery disease
- blood brain barrier
- mesenchymal stem cells
- left ventricular